FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3144045114> ?p ?o ?g. }

• W3144045114 endingPage "68" @default.
• W3144045114 startingPage "61" @default.
• W3144045114 abstract "The safety of selected polyethylene glycols (PEGS) Lanolin polymers was previously reviewed. This review completes the safety assessment of all the PEGs Lanolin polymers and related cosmetic ingredients. PEGs Lanolin are prepared by ethoxylating the hydroxy fatty acids, hydroxy esters, sterols, and alcohols present in whole lanolin. The number of moles of ethylene oxide reacted with each respective lanolin component corresponds to the average polyethylene glycol chain length. PEGs Lanolins, PEGs Hydrogenated Lanolins, PEG Lanolin Oil, and PEG Lanolin Wax are used as emulsifying, soluhilizing, and cleansing agents. PEGs Hydrogenated Lanolins are also hair-conditioning agents and skin-conditioning emollients. Few data on the PEGs Lanolin were available regarding systemic toxicity, mutagenicity, carcinogenicity, and clinical safety. Related compounds including PEGs, Lanolin, and Lanolin Oil have been previously reviewed. Based on clinical data in burn patients, PEGs were mild irritants/sensitizers and there was evidence of nephrotoxicity. No such effects were seen in animal studies on intact skin. Cosmetic manufacturers should continue to adjust product formulations to minimize any untoward effects when products are used on damaged skin. No evidence of phototoxic effects was found in clinical studies. Comedogenic effects have resulted from the use of cosmetic products containing lanolin compounds. No evidence of mutagenicity, carcinogenicity, or reproductive and developmental toxicity was found with these related compounds. Although metabolites of ethylene glycol monoalkyl ethers are reproductive and developmental toxins, it was considered unlikely that the relevant metabolites would be found in or produced from the use of PEGs Cocamine in cosmetic formulations. Based primarily on data from ingredients with related structures, it was concluded that PEG-S, -10, -24, -25, -35, -55, -100, and -150 Lanolin; PEG-S, -10, -20, -24, -30, and -70 Hydrogenated Lanolin; PEG-75 Lanolin Oil; and PEG-75 Lanolin Wax are safe for use in cosmetic formulations under the present practices of use." @default.
• W3144045114 created "2021-04-13" @default.
• W3144045114 date "1999-01-01" @default.
• W3144045114 modified "2023-10-14" @default.
• W3144045114 title "Addendum to the Final Report on the Safety Assessment of PEGs Lanolin to Include PEG-5, -10, -24, -25, -35, -55, -100, and -150 Lanolin; PEG-5, -10, -20, -24, -30, and -70 Hydrogenated Lanolin; PEG-75 Lanolin Oil; and PEG-75 Lanolin Wax¹" @default.
• W3144045114 cites W2058726373 @default.
• W3144045114 cites W2086517634 @default.
• W3144045114 cites W2092043408 @default.
• W3144045114 doi "https://doi.org/10.1177/109158189901801s06" @default.
• W3144045114 hasPublicationYear "1999" @default.
• W3144045114 type Work @default.
• W3144045114 sameAs 3144045114 @default.
• W3144045114 citedByCount "0" @default.
• W3144045114 crossrefType "journal-article" @default.
• W3144045114 hasBestOaLocation W31440451141 @default.
• W3144045114 hasConcept C10138342 @default.
• W3144045114 hasConcept C153033020 @default.
• W3144045114 hasConcept C162324750 @default.
• W3144045114 hasConcept C178790620 @default.
• W3144045114 hasConcept C185592680 @default.
• W3144045114 hasConcept C2776964284 @default.
• W3144045114 hasConcept C2780758404 @default.
• W3144045114 hasConcept C31903555 @default.
• W3144045114 hasConcept C33070731 @default.
• W3144045114 hasConcept C43617362 @default.
• W3144045114 hasConcept C54400483 @default.
• W3144045114 hasConcept C86803240 @default.
• W3144045114 hasConceptScore W3144045114C10138342 @default.
• W3144045114 hasConceptScore W3144045114C153033020 @default.
• W3144045114 hasConceptScore W3144045114C162324750 @default.
• W3144045114 hasConceptScore W3144045114C178790620 @default.
• W3144045114 hasConceptScore W3144045114C185592680 @default.
• W3144045114 hasConceptScore W3144045114C2776964284 @default.
• W3144045114 hasConceptScore W3144045114C2780758404 @default.
• W3144045114 hasConceptScore W3144045114C31903555 @default.
• W3144045114 hasConceptScore W3144045114C33070731 @default.
• W3144045114 hasConceptScore W3144045114C43617362 @default.
• W3144045114 hasConceptScore W3144045114C54400483 @default.
• W3144045114 hasConceptScore W3144045114C86803240 @default.
• W3144045114 hasIssue "1_suppl" @default.
• W3144045114 hasLocation W31440451141 @default.
• W3144045114 hasOpenAccess W3144045114 @default.
• W3144045114 hasPrimaryLocation W31440451141 @default.
• W3144045114 hasRelatedWork W1949434334 @default.
• W3144045114 hasRelatedWork W2000938071 @default.
• W3144045114 hasRelatedWork W2020650869 @default.
• W3144045114 hasRelatedWork W2052804438 @default.
• W3144045114 hasRelatedWork W2058889075 @default.
• W3144045114 hasRelatedWork W2068274848 @default.
• W3144045114 hasRelatedWork W2150895058 @default.
• W3144045114 hasRelatedWork W3141521293 @default.
• W3144045114 hasRelatedWork W4231642438 @default.
• W3144045114 hasRelatedWork W4237497721 @default.
• W3144045114 hasVolume "18" @default.
• W3144045114 isParatext "false" @default.
• W3144045114 isRetracted "false" @default.
• W3144045114 magId "3144045114" @default.
• W3144045114 workType "article" @default.